N. Yasui-Furukori

发表

Lithium in Tap Water and Suicide Mortality in Japan

T. Terao, N. Ishii, N. Iwata, 2013, International journal of environmental research and public health.

Factor structure of the University Personality Inventory in Japanese medical students

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2020, BMC Psychology.

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia

Norio Sugawara, N. Yasui-Furukori, T. Sumiyoshi, 2019, Front. Psychiatry.

The Effect of Aging on the Relationship between the Cytochrome P450 2C19 Genotype and Omeprazole Pharmacokinetics

M. Sasaki, N. Yasui-Furukori, Yukio Ishizawa, 2005, Clinical pharmacokinetics.

Relationship Between Dietary Patterns and Cognitive Function in a Community-Dwelling Population in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2015, Asia-Pacific journal of public health.

Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes.

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2005, Chirality.

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2016, Neuropsychiatric disease and treatment.

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Carbamazepine Decreases Antihypertensive Effect of Nilvadipine

N. Yasui-Furukori, T. Tateishi, N. Yasui‐Furukori, 2002, Journal of clinical pharmacology.

The Effects of Fluvoxamine on the Steady-State Plasma Concentrations of Escitalopram and Desmethylescitalopram in Depressed Japanese Patients

N. Yasui-Furukori, Kazuhiko Nakamura, Y. Inoue, 2016, Therapeutic drug monitoring.

Preanalysis Storage Conditions Influence the Measurement of Brain-Derived Neurotrophic Factor Levels in Peripheral Blood

Norio Sugawara, N. Yasui-Furukori, S. Tsuchimine, 2014, Neuropsychobiology.

The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers

N. Yasui-Furukori, Y. Akamine, S. Yamada, 2013, European Journal of Clinical Pharmacology.

Hydroxylation of R(+)- and S(−)-Omeprazole after Racemic Dosing are Different among the CYP2C19 Genotypes

N. Yasui-Furukori, Y. Akamine, S. Yamada, 2012, Pharmaceutical Research.

Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.

N. Yasui-Furukori, H. Shiohira, T. Uno, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations

M. Hayakari, N. Yasui-Furukori, T. Niioka, 2007, European Journal of Clinical Pharmacology.

Effects of multiple‐dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers

N. Yasui-Furukori, M. Miura, I. Ieiri, 2015, Journal of Clinical Pharmacy and Therapeutics.

Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy.

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2019, Journal of clinical psychopharmacology.

Association between oxidative stress-related genes polymorphisms and metabolic abnormalities among schizophrenia patients

Norio Sugawara, N. Yasui-Furukori, K. Oniki, 2017 .

Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study

Norio Sugawara, N. Yasui-Furukori, K. Oniki, 2016, Psychiatry Research.

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study.

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2021, Journal of Alzheimer's disease : JAD.

Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2021, Journal of Alzheimer's Disease.

Body mass index and quality of life among outpatients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2013, BMC Psychiatry.

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2021, Neuropsychopharmacology reports.

Relationship of Prolactin Concentrations to Steady-state Plasma Concentrations of Aripiprazole in Schizophrenia Patients.

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2020, Therapeutic drug monitoring.

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole

N. Yasui-Furukori, M. Miura, H. Kagaya, 2006, Xenobiotica; the fate of foreign compounds in biological systems.

The Effects of Ginkgo biloba Extracts on the Pharmacokinetics and Pharmacodynamics of Donepezil

N. Yasui-Furukori, S. Kaneko, T. Tateishi, 2004, Journal of clinical pharmacology.

Dose-Dependent Interaction of Paroxetine With Risperidone in Schizophrenic Patients

N. Yasui-Furukori, S. Kaneko, M. Saito, 2005, Journal of clinical psychopharmacology.

Effects of nutritional education on weight change and metabolic abnormalities among patients with schizophrenia in Japan: A randomized controlled trial.

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2018, Journal of psychiatric research.

Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2005, British journal of clinical pharmacology.

Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

A. Munakata, N. Yasui-Furukori, T. Uno, 2005, British journal of clinical pharmacology.

Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.

N. Yasui-Furukori, R. Vries, S. Kaneko, 2005 .

Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.

Yoshinao Abe, N. Yasui-Furukori, M. Aoki, 2004, Japanese journal of clinical oncology.

Factor structure of the Liebowitz Social Anxiety Scale in community‐dwelling subjects in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Psychiatry and clinical neurosciences.

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2016, Neuropsychiatric disease and treatment.

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Annals of general psychiatry.

Prevalence of metabolic syndrome among patients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Nakaji, 2010, Schizophrenia Research.

Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers

N. Yasui-Furukori, M. Miura, H. Kagaya, 2010, Xenobiotica; the fate of foreign compounds in biological systems.

Effects of the P-glycoprotein Inducer Carbamazepine on Fexofenadine Pharmacokinetics

N. Yasui-Furukori, S. Kaneko, Y. Akamine, 2009, Therapeutic drug monitoring.

Steady-State Pharmacokinetics of a New Antipsychotic Agent Perospirone and Its Active Metabolite, and Its Relationship with Prolactin Response

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2004, Therapeutic drug monitoring.

Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma

N. Yasui-Furukori, T. Niioka, Mikiko Shimizu, 2007, Cancer Chemotherapy and Pharmacology.

Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.

N. Yasui-Furukori, K. Otani, A. Suzuki, 2001, The American journal of psychiatry.

Tandospirone-Induced Rhabdomyolysis

N. Yasui-Furukori, Kensuke Miyazaki, M. Otaka, 2018, Clinical neuropharmacology.

Effects of selective serotonin reuptake inhibitors on the pharmacokinetics of proton pump inhibitors

N. Yasui-Furukori, Y. Akamine, T. Hirano, 2017 .

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Tsuchimine, 2015, PloS one.

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

T. Onitsuka, K. Ohi, N. Yasui-Furukori, 2022, Frontiers in Psychiatry.

Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.

N. Yasui-Furukori, S. Kaneko, Tetsu Tomita, 2013, Clinical neuropharmacology.

Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation

K. Yamakawa, N. Yasui-Furukori, H. Osaka, 2007, Epilepsy Research.

Neuroleptic malignant syndrome induced by lamotrigine.

Norio Sugawara, N. Yasui-Furukori, Masamichi Ishioka, 2013, Clinical neuropharmacology.

Association of the Taq I A Polymorphism of the Dopamine D 2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome

N. Yasui-Furukori, K. Otani, A. Suzuki, 2001 .

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.

N. Yasui-Furukori, Mikiko Shimizu, T. Uno, 2006, British journal of clinical pharmacology.

Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.

N. Yasui-Furukori, T. Uno, T. Takahata, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.

K. Kasai, T. Kishimoto, Tadasu Horai, 2022, Asian journal of psychiatry.

Toward recovery in schizophrenia: Current concepts, findings, and future research directions

Y. Hirano, T. Onitsuka, K. Miura, 2022, Psychiatry and clinical neurosciences.

The relationship between schizophrenia patients' attitudes towards physical health and the prevalence of metabolic syndrome

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2020, Clinical Neuropsychopharmacology and Therapeutics.

Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2016, Schizophrenia Research.

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2020, Neuropsychiatric disease and treatment.

NDT_A_269619 2229..2236

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2020 .

Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report

N. Yasui-Furukori, Kazuhiko Nakamura, K. Kishi, 2019, International medical case reports journal.

Heidenhain variant of Creutzfeldt–Jakob disease resembles dementia with Lewy bodies

Norio Sugawara, N. Yasui-Furukori, Shigeto Oyama, 2020, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study.

T. Onitsuka, K. Ohi, N. Yasui-Furukori, 2022, Asian journal of psychiatry.

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia

N. Yasui-Furukori, A. Suzuki, T. Kondo, 2007, Psychiatry and clinical neurosciences.

Clinical implications of pharmacogenetics of antidepressants

N. Yasui-Furukori, K. Otani, A. Suzuki, 2002 .

Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam.

N. Yasui-Furukori, S. Kaneko, T. Kondo, 2003, British journal of clinical pharmacology.

Effect of Itraconazole on Pharmacokinetics of Paroxetine: The Role of Gut Transporters

N. Yasui-Furukori, T. Niioka, S. Kaneko, 2007, Therapeutic Drug Monitoring.

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P‐glycoprotein in risperidone disposition

N. Yasui-Furukori, M. Saito, T. Tateishi, 2005, Clinical pharmacology and therapeutics.

Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects.

A. Munakata, S. Sasaki, K. Okumura, 2003, Life sciences.

Effect of age and disease on bone mass in Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Annals of General Psychiatry.

Effect of age and sex on prescriptions for outpatients with bipolar disorder in the MUSUBI study: a cross‑sectional study

R. Yoshimura, A. Nakagawa, N. Yasui-Furukori, 2022, Annals of General Psychiatry.

Working status of caregivers for people with dementia: Analysis data from a Japanese Nationwide Survey

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2020, PloS one.

Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese

N. Yasui-Furukori, S. Kaneko, M. Saito, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.

N. Yasui-Furukori, M. Miura, H. Kagaya, 2006, British journal of clinical pharmacology.

Psychotropic Drug–Drug Interactions Involving P-Glycoprotein

N. Yasui-Furukori, I. Ieiri, Y. Akamine, 2012, CNS Drugs.

Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.

N. Yasui-Furukori, Mikiko Shimizu, T. Uno, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals

N. Yasui-Furukori, S. Kaneko, S. Tsuchimine, 2013, PloS one.

Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.

N. Yasui-Furukori, A. Suzuki, S. Kaneko, 2004, British journal of clinical pharmacology.

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine

N. Yasui-Furukori, J. Saruwatari, Norio Yasui-Furukori, 2014, BMJ Open.

Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis

N. Yasui-Furukori, K. Oniki, J. Saruwatari, 2016, Pharmacogenetics and genomics.

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2018, Neuropsychiatric disease and treatment.

No association between bone mass and prolactin levels among patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Human psychopharmacology.

Poor Reliability of Therapeutic Drug Monitoring Data for Haloperidol and Bromperidol Using Enzyme Immunoassay

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2003, Therapeutic drug monitoring.

Real-world predictors of changes in fear of COVID-19 in the Japanese general population: a large-scale internet-based cohort study with 20,712 participants

Norio Sugawara, N. Yasui-Furukori, Keita Tokumitsu, 2024, BMC psychiatry.

The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer’s disease than MMSE alone

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2021, PloS one.

Dietary patterns are associated with obesity in Japanese patients with schizophrenia

Manabu Saito, Norio Sugawara, N. Yasui-Furukori, 2014, BMC Psychiatry.

No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Human psychopharmacology.

Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Association between the dopamine D2 receptor (DRD2) polymorphism and the personality traits of healthy Japanese participants

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Mutational analysis of CACNA1G in idiopathic generalized epilepsy

K. Yamakawa, A. Delgado-Escueta, P. Lory, 2007, Human mutation.

Higher plasma leptin and lower C-peptide levels are associated with depression: A cross-sectional study.

T. Kudo, N. Yasui-Furukori, K. Hirota, 2019, Journal of affective disorders.

Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder

N. Yasui-Furukori, Kazuhiko Nakamura, S. Kaneko, 2016, Clinical neuropharmacology.

Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

N. Yasui-Furukori, T. Kondo, K. Otani, 2001, European Archives of Psychiatry and Clinical Neuroscience.

Age and gender differences in the factor structure of the Center for Epidemiological Studies Depression Scale among Japanese working individuals.

Norio Sugawara, N. Yasui-Furukori, S. Nakaji, 2015, Comprehensive psychiatry.

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2014, Neuropsychiatric disease and treatment.

Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Journal of clinical psychopharmacology.

Effect of grapefruit juice in relation to human pharmacokinetic study.

N. Yasui-Furukori, T. Uno, N. Yasui‐Furukori, 2006, Current clinical pharmacology.

Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.

N. Yasui-Furukori, Y. Akamine, T. Uno, 2019, Current drug metabolism.

The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.

N. Yasui-Furukori, I. Tamai, M. Miura, 2015, Drug metabolism and pharmacokinetics.

Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers

H. Kusuhara, N. Yasui-Furukori, I. Tamai, 2014, European Journal of Clinical Pharmacology.

Effect of Coadministration of Single and Multiple Doses of Rifampicin on the Pharmacokinetics of Fexofenadine Enantiomers in Healthy Subjects

H. Kusuhara, Y. Sugiyama, N. Yasui-Furukori, 2013, Drug Metabolism and Disposition.

Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers.

N. Yasui-Furukori, M. Miura, Y. Akamine, 2012, British journal of clinical pharmacology.

Different Effects of Three Transporting Inhibitors, Verapamil, Cimetidine, and Probenecid, on Fexofenadine Pharmacokinetics

N. Yasui-Furukori, Kazunobu Sugawara, Norio Yasui-Furukori, 2005, Clinical pharmacology and therapeutics.

Different Effects of the Selective Serotonin Reuptake Inhibitors Fluvoxamine, Paroxetine, and Sertraline on the Pharmacokinetics of Fexofenadine in Healthy Volunteers

N. Yasui-Furukori, T. Niioka, J. Saruwatari, 2012, Journal of clinical psychopharmacology.

Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.

N. Yasui-Furukori, S. Kaneko, R. de Vries, 2004, Journal of Clinical Psychopharmacology.

Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2004, Psychopharmacology.

Effects of Various CYP2D6 Genotypes on the Steady-State Plasma Concentrations of Risperidone and Its Active Metabolite, 9-Hydroxyrisperidone, in Japanese Patients With Schizophrenia

T. Iga, N. Yasui-Furukori, Y. Takarada, 2003, Therapeutic drug monitoring.

Effects of CYP2D6 Genotypes on Plasma Concentrations of Risperidone and Enantiomers of 9‐Hydroxyrisperidone in Japanese Patients with Schizophrenia

T. Iga, N. Yasui-Furukori, Y. Takarada, 2003, Journal of clinical pharmacology.

Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.

N. Yasui-Furukori, E. Spina, M. G. Scordo, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Effects of personality on the association between paroxetine plasma concentration and response

N. Yasui-Furukori, Kazuhiko Nakamura, S. Tsuchimine, 2018, Neuropsychiatric disease and treatment.

Therapeutic Reference Range for Plasma Concentrations of Paroxetine in Patients With Major Depressive Disorders

N. Yasui-Furukori, Kazuhiko Nakamura, S. Kaneko, 2014, Therapeutic drug monitoring.

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2014, PloS one.

Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders

N. Yasui-Furukori, K. Otani, A. Suzuki, 2011, Human psychopharmacology.

Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2011, Human psychopharmacology.

Digitalis intoxication induced by paroxetine co-administration

N. Yasui-Furukori, S. Kaneko, N. Yasui‐Furukori, 2006, The Lancet.

The relationship of stress coping styles on substance use, depressive symptoms, and personality traits of nurses in higher education institution

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2023, Neuropsychopharmacology reports.

A crossover study on the glucose metabolism between treatment with olanzapine and risperidone in schizophrenic patients.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2010, Experimental and clinical psychopharmacology.

Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2009, The Journal of clinical psychiatry.

No association between CYP2D6 polymorphisms and personality trait in Japanese.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2007, British journal of clinical pharmacology.

Concordance of Lateralization Index for Brain Asymmetry Applied to Identify a Reliable Language Task

K. Matsuo, N. Yasui-Furukori, K. Akiyama, 2023, Symmetry.

Development and validation of the Japanese version of EPDS‐P for indirect screening of paternal perinatal depression based on maternal reporting: Protocol for a prospective longitudinal observational study

C. Yamada, Norio Sugawara, N. Yasui-Furukori, 2023, Neuropsychopharmacology reports.

Prevalence of perinatal depression among Japanese men: a meta-analysis

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2020, Annals of General Psychiatry.

Prevalence of perinatal depression among Japanese women: a meta-analysis

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2020, Annals of General Psychiatry.

Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Human psychopharmacology.

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study

T. Kishimoto, K. Ohi, N. Yasui-Furukori, 2023, Psychiatry and clinical neurosciences.

Determinants of three-year clinical outcomes in real-world outpatients with bipolar disorder: The multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI).

R. Yoshimura, A. Nakagawa, Norio Sugawara, 2022, Journal of psychiatric research.

Prevalence of underweight in patients with schizophrenia: A meta-analysis

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2017, Schizophrenia Research.

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2018, BMC Psychiatry.

Effect of antipsychotic use by patients with schizophrenia on deceleration capacity and its relation to the corrected QT interval.

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2023, General hospital psychiatry.

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2021, Neuropsychiatric disease and treatment.

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2021 .

Dietary patterns and schizophrenia: a comparison with healthy controls

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.

Naoshi Kaneko, Hiroki Shibata, Takashi Asada, 2005, American journal of human genetics.

Effect of concomitant use of yokukansan on steady-state blood concentrations of donepezil and risperidone in real-world clinical practice.

N. Yasui-Furukori, K. Oniki, J. Saruwatari, 2024, Neuropsychopharmacology reports.

The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.

N. Yasui-Furukori, K. Oniki, K. Nakagawa, 2016, Biological & pharmaceutical bulletin.

Item response theory analysis of the University Personality Inventory in medical students

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2023, Neuropsychopharmacology reports.

New Insight Concerning Therapeutic Drug Monitoring-The Importance of the Concept of Psychonephrology.

N. Yasui-Furukori, K. Oniki, J. Saruwatari, 2022, Biological & pharmaceutical bulletin.

Delirium in hemodialysis predicts mortality: a single-center, long-term observational study

Norio Sugawara, N. Yasui-Furukori, C. Ohyama, 2017, Neuropsychiatric disease and treatment.

Pharmacological management of bipolar disorder: Japanese expert consensus

N. Yasui-Furukori, H. Baba, Koichiro Watanabe, 2020, Bipolar disorders.

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study

Norio Sugawara, N. Yasui-Furukori, I. Takahashi, 2014, Neuropsychiatric disease and treatment.

Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals

N. Yasui-Furukori, S. Kaneko, M. Saito, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Relationships between Vascular Endothelial Growth Factor Levels and Temperament and Character Inventory Traits in Healthy Japanese Subjects

N. Yasui-Furukori, S. Kaneko, S. Tsuchimine, 2013, Neuropsychobiology.

The influence of personality factors on paroxetine response time in patients with major depression.

N. Yasui-Furukori, S. Kaneko, A. Kaneda, 2011, Journal of affective disorders.

Projections of psychiatrists’ distribution for patients in Japan: a utilization-based approach

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2020, Human Resources for Health.

Single Oral Dose Pharmacokinetics of Quazepam Is Influenced by CYP2C19 Activity

N. Yasui-Furukori, K. Otani, A. Suzuki, 2004, Therapeutic drug monitoring.

Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes.

L. Bertilsson, N. Yasui-Furukori, L. Gustafsson, 2003, British journal of clinical pharmacology.

Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project

R. Yoshimura, A. Nakagawa, N. Yasui-Furukori, 2021, Neuropsychiatric disease and treatment.

Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI).

T. Kinoshita, R. Yoshimura, A. Nakagawa, 2020, Journal of psychiatric research.

Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression

N. Yasui-Furukori, S. Kaneko, M. Saito, 2015, Psychiatry Research.

Minor genetic variants of the dopamine D4 receptor (DRD4) polymorphism are associated with novelty seeking in healthy Japanese subjects

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

A. Nakagawa, Norio Sugawara, N. Yasui-Furukori, 2023, Annals of General Psychiatry.

Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study

R. Yoshimura, A. Nakagawa, N. Yasui-Furukori, 2022, Neuropsychiatric disease and treatment.

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

R. Yoshimura, A. Nakagawa, N. Yasui-Furukori, 2020, BMC Psychiatry.

Development of individualized medicine for epilepsy based on genetic information

N. Yasui-Furukori, H. Iwasa, K. Kanai, 2008, Expert review of clinical pharmacology.

Association between plasma brain-derived neurotrophic factor levels and personality traits in healthy Japanese subjects

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2013, Psychiatry Research.

A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.

N. Yasui-Furukori, Y. Akamine, Y. Inoue, 2010, Journal of separation science.

Histamine H1-Receptor Antagonists, Promethazine and Homochlorcyclizine, Increase the Steady-State Plasma Concentrations of Haloperidol and Reduced Haloperidol

N. Yasui-Furukori, K. Otani, A. Suzuki, 2003, Therapeutic drug monitoring.

Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers

M. Hayakari, N. Yasui-Furukori, M. Miura, 2008, European Journal of Clinical Pharmacology.

Identification of a Single Time-point for Plasma Lansoprazole Measurement That Adequately Reflects Area Under the Concentration-Time Curve

N. Yasui-Furukori, T. Niioka, S. Kaneko, 2006, Therapeutic drug monitoring.

Effects of Fluvoxamine on Lansoprazole Pharmacokinetics in Relation to CYP2C19 Genotypes

N. Yasui-Furukori, T. Uno, T. Takahata, 2004, Journal of clinical pharmacology.

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes

N. Yasui-Furukori, M. Miura, H. Tada, 2004, European Journal of Clinical Pharmacology.

PHARMACOKINETICS A ND D ISPOSITION

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2002 .

The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the “Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)” project

T. Onitsuka, T. Kishimoto, K. Ohi, 2022, Annals of General Psychiatry.

hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Norio Sugawara, N. Yasui-Furukori, Masamichi Ishioka, 2015 .

Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients

N. Yasui-Furukori, K. Akiyama, K. Shimoda, 2015, Pharmacopsychiatry.

Update on the development of lurasidone as a treatment for patients with acute schizophrenia

N. Yasui-Furukori, N. Yasui‐Furukori, 2012, Drug design, development and therapy.

Personality associated with depressive status in individuals with type 2 diabetes mellitus

Norio Sugawara, N. Yasui-Furukori, J. Tanabe, 2019, Neuropsychiatric disease and treatment.

Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients

N. Yasui-Furukori, S. Kaneko, M. Saito, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome

N. Yasui-Furukori, K. Otani, A. Suzuki, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

The associations of the number of medications and the use of anticholinergics with recovery from tubal feeding: a longitudinal hospital-based study

Norio Sugawara, N. Yasui-Furukori, K. Oniki, 2020, BMC Geriatrics.

Association between insomnia and personality traits among Japanese patients with type 2 diabetes mellitus

Norio Sugawara, N. Yasui-Furukori, J. Tanabe, 2018, Journal of diabetes investigation.

Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus

Norio Sugawara, N. Yasui-Furukori, J. Tanabe, 2018, Neuropsychiatric disease and treatment.

Second-generation antipsychotics and bone turnover in schizophrenia

N. Kanahara, M. Iyo, F. Nomura, 2014, Schizophrenia Research.

Takotsubo cardiomyopathy after hypoglycemia in a patient with anorexia nervosa

N. Yasui-Furukori, K. Shimoda, K. Kikuchi, 2021, Annals of General Psychiatry.

Bemegride lengthens seizure duration during electric convulsive therapy in a schizophrenic patient with increased seizure threshold.

N. Yasui-Furukori, S. Kaneko, H. Katagai, 2009, The journal of ECT.